In a cramped conference room in Geneva, diplomats from countries around the world spent two weeks in July 2026 doing something that might sound boring but could actually save millions of lives someday: arguing about germs.

More specifically, they were hammering out the details of a system to make sure that when a dangerous new pathogen — say, a virus that sparks the next pandemic — is discovered, countries share it quickly with each other. And just as importantly, they worked on making sure that when vaccines or treatments are made from those pathogens, the benefits reach everyone fairly, not just the richest nations.

This system is called the Pathogen Access and Benefit Sharing annex. Think of it as a rulebook for how countries should trade information about deadly germs and the medicines that fight them. The latest round of talks, the seventh meeting of this working group, wrapped up on July 17 in Geneva, Switzerland.

"While differences remain, those differences can be bridged if we keep our shared goal in sight: a world where pathogens and scientific information are shared rapidly, and the benefits they generate are shared fairly and equitably," said Dr. Tedros Adhanom Ghebreyesus, head of the World Health Organization. "The next pandemic will not wait. Neither should we."

One major sticking point involves how laboratory networks handle and share pathogen samples — including the genetic sequence information that scientists use to develop tests and vaccines. Countries also need to agree on what counts as a "benefit" that should be shared, and how contractual arrangements between nations should work.

Still, negotiators reported real progress. "Over the past two weeks, we have made meaningful progress on some of the most technically and politically complex elements of the PABS annex," said Ambassador Tovar da Silva Nunes of Brazil, who co-chairs the working group alongside Matthew Harpur. "The remaining issues are challenging, but we have a clear path to completing this important work."

The context for all this is the COVID-19 pandemic, which exposed deep inequities in how vaccines and medical supplies were distributed globally. Wealthier countries hoarded doses while poorer ones waited years. The new PABS system aims to prevent that from happening again by building fairness into the system from the start.

The World Health Assembly first adopted the broader Pandemic Agreement in May 2025. Finalizing the PABS annex is the last major step before countries can officially sign and ratify it — the legal process that turns a promise into law. The next round of negotiations is scheduled for September 2026.

For everyday people, the stakes are straightforward: a faster, fairer system for sharing germs and medicines could mean quicker access to vaccines the next time a new disease emerges. It is slow, painstaking diplomacy — but it might determine who lives and who dies when the next pandemic hits.